comparemela.com

Latest Breaking News On - Therapies summit - Page 1 : comparemela.com

Enara Bio to present progress of research on novel, cancer-specific, MR1-restricted TCRs at upcoming TCR-based Therapies Summit

Enara Bio to present progress of research on novel, cancer-specific, MR1-restricted TCRs at upcoming TCR-based Therapies Summit    Oxford and London, UK – 09 June 2021. Enara Bio, a biotechnology company leveraging its proprietary T-cell/T-cell receptor (TCR) and Dark Antigen™ discovery pl.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.